New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 12, 2013
07:35 EDTSTEMStemCells announces first patient cohort completes spinal cord injury trial
StemCells announced that the twelve-month data from the first patient cohort in the company's Phase I/II clinical trial of its proprietary HuCNS-SC product candidate, or purified human neural stem cells, for chronic spinal cord injury continued to demonstrate a favorable safety profile, and showed that the considerable gains in sensory function observed in two of the three patients at the six-month assessment have persisted. The third patient remains stable.
News For STEM From The Last 14 Days
Check below for free stories on STEM the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for STEM

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use